Sonendo Inc Stock Price, News & Analysis

Sonendo, Inc. (NYSE: SONX) announced that its subsidiary, PIPStek LLC, has filed a patent infringement lawsuit against BIOLASE, Inc. in the U.S. District Court for Delaware. The suit asserts that BIOLASE's Waterlase laser infringes on two patents owned by PIPStek. Sonendo acquired PIPStek in 2017, securing its intellectual property, which includes dental laser technologies. CEO Bjarne Bergheim emphasized their commitment to protect intellectual property and expressed confidence in a favorable court ruling.

Sonendo, a dental technology leader, reported Q3 2022 financials with total revenue of $9.8 million, up 25% from Q3 2021. Consumable revenue reached $4.8 million, marking a 30% increase year-over-year. The GentleWave install base grew to approximately 935 units. A private financing round yielded $63 million. However, the gross margin declined to 24%, and the company reported a loss from operations of $14.6 million. Full-year 2022 revenue guidance is $40.5 million to $42.5 million, reflecting 22%-28% growth.

Sonendo, Inc. (NYSE: SONX), a dental technology leader, will participate in the Stifel 2022 Healthcare Conference on November 15 at 10:55 a.m. Eastern Time. An audio webcast will be available on their website. Sonendo focuses on innovative treatments for tooth decay via the patented GentleWave® System, offering less invasive procedures with improved clinical outcomes. The company also owns TDO Software, enhancing dental practice management.

Sonendo has received Health Canada regulatory approval for its GentleWave G4 System, aimed at improving the treatment of tooth decay in Canada. This next-generation technology enhances user experience with a simplified workflow and advanced features, including battery backup and multi-operatory connectivity. A recent clinical trial showed that 99.5% of patients reported no pain during procedures using GentleWave Technology. This approval marks a significant expansion of Sonendo’s product offerings in Canada, reinforcing its commitment to endodontic practices.

Sonendo, Inc. (NYSE: SONX) is set to release its financial results for Q3 2022 on November 9, 2022, after market close. The management will hold a conference call at 1:30 p.m. PT to discuss results. The GentleWave® System, developed by Sonendo, aims to enhance dental procedures by cleaning tooth decay without removing tooth structure, offering improved patient outcomes. The company also owns TDO® Software, which streamlines endodontic practice management.

Sonendo has launched the GentleWave G4 System, an advanced dental technology aimed at enhancing root canal treatment. The system features improved workflow, broad-spectrum acoustic energy, and advanced fluid dynamics for superior cleaning and patient outcomes. A recent clinical trial indicated that 99.5% of patients experienced minimal to no pain during the procedure. The G4 system is designed for future upgradeability and operational efficiency with features like battery backup and multi-operatory connectivity, enhancing both patient care and practice productivity.

Sonendo, Inc. (NYSE: SONX) has announced its second annual EndoCon, an endodontic conference focused on innovation, to take place in San Diego from October 20-22. The event will offer hands-on learning, lectures, and networking opportunities for clinicians and staff, featuring keynote speakers Joel Goldberg and Jessica Metcalfe. With over 400 attendees last year, EndoCon aims to enhance knowledge and skills in modern endodontics through interactive sessions and industry expert insights.